Myeloproliferative Neoplasms Panel - Disclosures
|
Panel Member
|
Peter Abdelmessieh DO, MSc |
|
Product/Speakers Bureau
|
| Amgen Inc. |
|
Date Completed
|
11/03/2024 |
|
Panel Member
|
Haris Ali MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Mary Anne Bergman |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Mariana Castells MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Manuel Espinoza-Gutarra MD |
|
Fellowship Support
|
| Bristol Myers Squibb |
|
Date Completed
|
03/31/2025 |
|
Panel Member
|
Ruth Fein Revell BS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Aaron Gerds MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jason Gotlib MD, MS |
|
Grant/Research Support
|
| AbbVie, Inc. | Blueprint Medicines | Bristol Myers Squibb | Cogent Biosciences | Incyte Corporation | Merck & Co., Inc. | Protagonist Therapeutics | Telios |
|
Date Completed
|
03/24/2025 |
|
Panel Member
|
Steven Green MD |
|
Product/Speakers Bureau
|
| GSK |
|
Date Completed
|
02/01/2025 |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Krishna Gundabolu MBBS, MS, FACP |
|
Equity Interest/Stock Options
|
| Geron |
|
Date Completed
|
10/14/2024 |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Elizabeth Hexner MD, MS |
|
Grant/Research Support
|
| AbbVie, Inc. |
|
Date Completed
|
08/21/2024 |
|
Panel Member
|
Cindy Hochstetler PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Tania Jain MBBS |
|
Grant/Research Support
|
| Incyte Corporation | Kartos therapeutics | Karyopharm Therapeutics | Tscan therapuetics |
|
Date Completed
|
05/12/2025 |
|
Panel Member
|
catriona Jamieson MD, PhD |
|
Equity Interest/Stock Options
|
| Aspera Biomedicines |
|
Date Completed
|
02/04/2025 |
|
Panel Member
|
Paul Kaesberg MD |
|
Product/Speakers Bureau
|
| BeiGene | Janssen Pharmaceutica Products, LP |
|
Date Completed
|
05/14/2024 |
|
Panel Member
|
Irum Khan MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Andrew Kuykendall MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Yazan Madanat MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Naveen Manchanda MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lucia Masarova MD |
|
Grant/Research Support
|
| GSK |
|
Date Completed
|
08/05/2024 |
|
Panel Member
|
Christine McLaughlin |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Brandon McMahon MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sanjay Mohan MD, MSCI |
|
Grant/Research Support
|
| Incyte Corporation | Kartos | Karyopharm Therapeutics | Taiho Pharmaceuticals Co., Ltd. |
|
Date Completed
|
03/06/2025 |
|
Panel Member
|
Kalyan Nadiminti MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Stephen Oh MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jeanne Palmer MD |
|
Grant/Research Support
|
| Ionis |
|
Date Completed
|
11/02/2024 |
|
Panel Member
|
Ami Patel MD |
|
Grant/Research Support
|
| Genentech, Inc. |
|
Date Completed
|
01/30/2025 |
|
Panel Member
|
Anand Patel MD |
|
Grant/Research Support
|
| Incyte Corporation | Kronos Bio | Pfizer Inc. | Servier | Sumitomo |
|
Date Completed
|
01/14/2025 |
|
Panel Member
|
Nikolai Podoltsev MD, PhD |
|
Grant/Research Support
|
| , Arog Pharmaceuticals | AI Therapeutics | Aptose Biosciences | Astellas Pharma US, Inc. | Astex Pharmaceuticals | Boehringer Ingelheim | Celgene Corporation | CTI BioPharma Corp. | Daiichi- Sankyo Co. | Genentech, Inc. | Jazz Pharmaceuticals Inc. | Kartos Therapeutics | Karyopharm Therapeutics | MorphoSys AG | Pfizer Inc. | Samus Therapeutics | Sunesis Pharmaceuticals, Inc. |
|
Date Completed
|
06/18/2024 |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lindsay Rein MD |
|
Grant/Research Support
|
| Blueprint Medicines | Cogent | Geron | Incyte Corporation | Karyopharm Therapeutics | Merck & Co., Inc. | Novartis Pharmaceuticals Corporation | PharmaEssentia | Protagonist | Sumitomo Dainippon Pharma | Telios |
|
Date Completed
|
07/30/2024 |
|
Panel Member
|
Tim Rinehart |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rachel Salit MD |
|
Grant/Research Support
|
| Incyte Corporation |
|
Date Completed
|
07/30/2024 |
|
Panel Member
|
Mary Sehl MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Moshe Talpaz MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Amanda Visnick BSN, RN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Martha Wadleigh MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sarah Wall MD, MPH |
|
Product/Speakers Bureau
|
| CTI BioPharma Corp. |
|
Date Completed
|
06/14/2024 |
